{"id":1218,"date":"2026-01-21T15:45:29","date_gmt":"2026-01-21T15:45:29","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/21\/brenig-launches-phase-1-trial-of-small-molecule-therapy-for-ms\/"},"modified":"2026-01-21T15:45:29","modified_gmt":"2026-01-21T15:45:29","slug":"brenig-launches-phase-1-trial-of-small-molecule-therapy-for-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/21\/brenig-launches-phase-1-trial-of-small-molecule-therapy-for-ms\/","title":{"rendered":"Brenig launches Phase 1 trial of small molecule therapy for MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/21\/brenig-launches-phase-1-trial-small-molecule-therapy-ms\/\" title=\"Brenig launches Phase 1 trial of small molecule therapy for MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2024\/12\/ClinicalTrialsClipboard-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"An oversized red pen ticks boxes marked &quot;Clinical&quot; and &quot;Trials&quot; on a checklist attached to a clipboard.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"144170\" \/><\/a><\/p>\n<p>Brenig Therapeutics has launched an early Phase 1 clinical trial to evaluate its experimental small molecule BT-409\u00a0in healthy volunteers. The therapy is being developed for people with multiple sclerosis (MS) and other chronic neurologic conditions. It is aimed at blocking inflammatory responses by targeting the NLRP3 inflammasome, an immune complex that is abnormally activated in [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/21\/brenig-launches-phase-1-trial-small-molecule-therapy-ms\/\">Brenig launches Phase 1 trial of small molecule therapy for MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/21\/brenig-launches-phase-1-trial-small-molecule-therapy-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brenig Therapeutics has launched an early Phase 1 clinical trial to evaluate its experimental small molecule BT-409\u00a0in healthy volunteers. The therapy is being developed for people with multiple sclerosis (MS) and other chronic neurologic conditions. It is aimed at blocking inflammatory responses by targeting the NLRP3 inflammasome, an immune complex that is abnormally activated in&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1219,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1218"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1218\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1219"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}